HPM Announces that Anne K. Walsh has Joined the Firm as Of CounselJanuary 4, 2011
Hyman, Phelps & McNamara, P.C. (“HPM”) is pleased to announce that Anne K. Walsh has joined the firm as Of Counsel. Prior to joining the firm in January 2011, Ms. Walsh served as an Associate Chief Counsel with the U.S. Food and Drug Administration’s Office of Chief Counsel from 2004 to 2010. She worked closely with federal prosecutors and law enforcement agencies to investigate, negotiate, and litigate civil and criminal violations of the Federal Food, Drug, and Cosmetic Act. Ms. Walsh has extensive knowledge of issues concerning health care fraud, off-label promotion, cGMP and reporting regulations, and clinical study fraud, as it relates to both corporate and individual liability. She has won numerous awards for her work in groundbreaking prosecutions and settlements, including cases involving pharmaceutical, medical device, and in vitro diagnostics companies. She also has experience advising on matters involving other FDA enforcement activities, including for-cause inspections, warning letters, and recalls.
Ms. Walsh graduated from the College of William and Mary in 1994 with a B.A. in economics, and with a J.D. in 1997. She is admitted to practice law in New York and the District of Columbia. After graduating from law school, Ms. Walsh worked as an attorney in private practice representing major pharmaceutical and medical device clients.